Patents by Inventor Rosy Eloy

Rosy Eloy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING A FILLER PRODUCT AND AT LEAST ONE BIORESORBABLE AND BIODEGRADABLE SILICA-BASED MATERIAL
    Publication number: 20140065221
    Abstract: A combination product including at least one filler product and at least at least one bioresorbable and biodegradable silica-based material, for treating incontinence or treating aging of the skin and scars. Also, a composition including, in a physiologically acceptable medium, at least one filler product and at least at least one bioresorbable and biodegradable silica-based material.
    Type: Application
    Filed: April 2, 2012
    Publication date: March 6, 2014
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Rosy Eloy, Anders Karlsson
  • Angiogenic composition
    Publication number: 20100190709
    Abstract: The present invention relates to a amphiphilic polymer in the preparation of a therapeutic composition for promoting angiogenesis at its site of administration, comprising a complex between a polymer and a PDGF, wherein the polymer is amphiphilic. In an embodiment, the PDGF is selected from the group of the PDGFs (platelet-derived growth factors) and the amphiphilic polymer is selected from the group: The invention relates also to the therapeutic composition is in the form of a gel, a cream, a solution, a spray, a paste or a patch or a dressing.
    Type: Application
    Filed: March 24, 2010
    Publication date: July 29, 2010
    Applicant: ADOCIA
    Inventors: Olivier Soula, Gerard Soula, Remi Soula, Rosy Eloy
  • Angiogenic composition
    Publication number: 20080293635
    Abstract: The present invention relates to a amphiphilic polymer in the preparation of a therapeutic composition for promoting angiogenesis at its site of administration, comprising a complex between a polymer and a PDGF, wherein the polymer is amphiphilic. In an embodiment, the PDGF is selected from the group of the PDGFs (platelet-derived growth factors) and the amphiphilic polymer is selected from the group: The invention relates also to the therapeutic composition is in the form of a gel, a cream, a solution, a spray, a paste or a patch or a dressing.
    Type: Application
    Filed: March 31, 2008
    Publication date: November 27, 2008
    Applicant: ADOCIA
    Inventors: Olivier Soula, Gerard Soula, Remi Soula, Rosy Eloy
  • Highly pure alkyl 2-cyanoacrylates
    Patent number: 6057472
    Abstract: A process for the preparation of a highly pure alkyl 2-cyanoacrylate, wherein alkyl has 1-10 C atoms, characterized in thata) formaldehyde is reacted with an alkyl cyanoacetate ester by means of a catalyst in a solvent mixture selected from the group comprising ethylacetate, diglyme, dichloroethane and benzene, yielding an oligo-(alkyl 2-cyanoacrylate);b) the product of (a) is separated in the form of a solid;c) the product of (b) is depolymerized under sulfur dioxide atmosphere free from other polymerization inhibitors to yield an alkyl 2-cyanoacrylate with a purity of 98-100%
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: May 2, 2000
    Assignee: Merck Patent GmbH
    Inventors: Valerie Sailhan, Rosy Eloy, Louis Giral, Fran.cedilla.ois Schue